BUZZ
VanEck Social Sentiment ETF·Financial Services
30.14
0.803%(+0.24)
Market ClosedLast Updated: — ET
52W L: $20.7652W H: $39.59
BUZZ NEWS
accessnewswire.com
Mar 12
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026
ESTERO, FL / ACCESS Newswire / March 12, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, announces its participation at The Health & Fitness (HFA) Show, scheduled for March 16-18 at the San Diego Convention Center. Aspire will feature its flagship caffeine product, BUZZ BOMB™, at the New Product Zone, a premier area of the event highlighting innovative solutions for the global fitness industry.
benzinga.com
Mar 10
XRP Rises As ETF Buzz Builds: What To Know
A key driver of the move was growing attention around the Kurv XRP Enhanced Income ETF, which is set to begin trading on Wednesday.
accessnewswire.com
Mar 10
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
Convenient Size at the Convenience Store ESTERO, FL / ACCESS Newswire / March 10, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), today announced that its subsidiary, Buzz Bomb Caffeine Company, is expanding its retail footprint with the launch of the BUZZ BOMB™ Convenience Store Pack. Convenience stores are where many of today's quick decisions happen, and the checkout counter plays a big role in those moments.
247wallst.com
Mar 4
The ETF That Lets Reddit Drive Its Portfolio Has a Serious Problem
VanEck Social Sentiment ETF ( NYSEARCA:BUZZ ) was built to capture stocks retail investors are actually talking about before that conversation moves prices.
accessnewswire.com
Feb 5
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit
ESTERO, FL / ACCESS Newswire / February 5, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), wholly owned subsidiary, Buzz Bomb Caffeine Company, a marketer of a proprietary sublingual caffeine supplement today announced its participation at The Sports & Active Nutrition Summit USA, scheduled for February 18-20 in San Diego, CA. Aspire will feature its flagship caffeine product, BUZZ BOMB™, at the event.
accessnewswire.com
Jan 22
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity
Strategic inventory of 100,000 20-packs now available to meet increasing demand for rapid-onset sublingual caffeine technology ESTERO, FL / ACCESS Newswire / January 22, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a leader in innovative patent-pending sublingual delivery technologies, today announced it has taken delivery of two million units of its flagship caffeine supplement, BUZZ BOMB™. This delivery marks a critical milestone in Aspire's commercialization strategy, introducing a comprehensive brand relaunch and redesigned packaging.
